United States Lipid Disorder Therapeutics Market Size, Share, Trend, Forecasts to 2035
According to a research report published by Spherical Insights & Consulting, the US Lipid Disorder Therapeutics Market is anticipated to reach USD 14.15 Billion by 2035, growing at a CAGR of 10.56% from 2025 to 2035. The market growth is attributed to the rising prevalence of lipid disorders such as hyperlipidemia and hypercholesterolemia, the rising proportion of the geriatric population, increasing research and development studies, and the growing focus on novel drug delivery systems.